⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 5, 2024Open Access

Supplementary Figure S6 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs

Ukhyun Jo Yasuhiro Arakawa Astrid Zimmermann Daiki Taniyama Makito Mizunuma Lisa M. Jenkins Tapan K. Maity Suresh Kumar Frank T. Zenke Naoko Takebe Yves Pommier

View Full Paper

Ask AI

Bookmark

Share

Abstract

This figure shows representative images in the treatment of TPT (topotecan) and M1774 in small cell lung cancer organoids, and profiling of cell viability and DNA-damage molecules after drug treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jo et al. (2024) studied this question.

synapsesocial.com/papers/68e614b1b6db6435875a755f https://doi.org/10.1158/1535-7163.26190699.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S6 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
2Supplementary Figure S6 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
3Supplementary Figure S6 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
4Supplementary Figure S7 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
5Supplementary Figure S7 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024

Supplementary Figure S4 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
Supplementary Figure S4 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024
Supplementary Figure S5 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs2024